Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Robert Downs

Optometrist Anaheim Hills, CA Doctor of Optometry

NPI 1093899817 CMS profile 1220153

5701 E Santa Ana Canyon Rd Ste H, Anaheim Hills, CA 92807

Open in the dashboard

General payments

$13,013

173 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Robert Downs of Anaheim Hills, CA is reported in the CMS Open Payments database as having received $13,013 across 173 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,684 17
2024 General $2,328 26
2023 General $1,489 19
2022 General $3,122 45
2021 General $1,828 19
2020 General $888 17
2019 General $1,674 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Downs
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Robert Downs were reported at $1,684. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Robert Downs Optometrist median Middle half National median
2019 $1,674 $159 $67–$371 $163
2020 $888 $72 $29–$165 $114
2021 $1,828 $125 $46–$292 $132
2022 $3,122 $162 $66–$374 $149
2023 $1,489 $177 $72–$406 $160
2024 $2,328 $188 $77–$427 $164
2025 $1,684 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alcon Vision LLC $2,445 41 payments
  2. Bausch & Lomb Americas Inc. $1,580 17 payments
  3. Bausch & Lomb, a division of Bausch Health US, LLC $1,333 16 payments
  4. Glaukos Corporation $1,268 11 payments
  5. Sight Sciences, Inc. $1,152 10 payments
  6. CooperVision Inc. $1,024 14 payments
  7. Optos, Inc. $742 10 payments
  8. AbbVie, Inc. $522 6 payments
  9. Visionix USA, Inc $365 7 payments
  10. MacuLogix, Inc. $301 7 payments
  11. Other $2,281 34 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $12,490 167 payments
  2. Entertainment $504 5 payments
  3. Gift $19 1 payment
Products named General payments · program years 2019–2025
  1. INFUSE $948 9 payments
  2. OMNI(R) SURGICAL SYSTEM (US) $822 6 payments
  3. Precision 1 $786 13 payments
  4. TOTAL30 $721 8 payments
  5. MyDay Contact Lens $686 8 payments
  6. ULTRA MULTIFOCAL TORIC $572 5 payments
  7. ULTRA $531 6 payments
  8. OCT OPHTHALMOSCOPE $530 7 payments
  9. PANORAMIC OPHTHALMOSCOPE Ophthalmology $530 7 payments
  10. PANORAMIC OPHTHALMOSCOPE Ophthalmology $530 7 payments
  11. Other $12,051 162 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

173 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record